NCM
BSX icon

Northwest Capital Management’s Boston Scientific BSX Stock Holding History

Northwest Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$9.76K – 111
2025
Q3 		$9.76K Buy
+100
New +$10.4K 0.01% 194

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Northwest Capital Management's BSX Position: Q4 2025 in Review

Northwest Capital Management sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 100 shares — an estimated $9.76K sold.

Northwest Capital Management first reported a position in BSX in Q3 2025 and held it in 1 quarter. The position peaked at $9.76K in Q3 2025. 1,783 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • Northwest Capital Management reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
  • Northwest Capital Management sold 100 Boston Scientific shares in Q4 2025, an estimated $9.76K.
  • Northwest Capital Management first reported a position in Boston Scientific in Q3 2025 and held it in 1 quarter.
  • Northwest Capital Management's Boston Scientific position peaked at $9.76K in Q3 2025.
  • 1,783 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Northwest Capital Management's 13F filing for Q4 2025, filed 26 Jan 2026.